<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group>
<journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group>
<issn pub-type="epub">1935-2735</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNTD-D-13-01228</article-id>
<article-id pub-id-type="doi">10.1371/journal.pntd.0002655</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Dermatology</subject><subj-group><subject>Skin infections</subject></subj-group></subj-group><subj-group><subject>Diagnostic medicine</subject></subj-group><subj-group><subject>Epidemiology</subject></subj-group><subj-group><subject>Infectious diseases</subject><subj-group><subject>Bacterial diseases</subject><subj-group><subject>Leprosy</subject></subj-group></subj-group></subj-group><subj-group><subject>Pathology and laboratory medicine</subject></subj-group><subj-group><subject>Tropical diseases</subject><subj-group><subject>Neglected tropical diseases</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>PCR-Based Techniques for Leprosy Diagnosis: From the Laboratory to the Clinic</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Martinez</surname><given-names>Alejandra Nóbrega</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn1"><sup>¤</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Talhari</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moraes</surname><given-names>Milton Ozório</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Talhari</surname><given-names>Sinésio</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Laboratório de Hanseníase, Instituto Oswaldo Cruz - Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Fundação Alfredo da Matta, Manaus, Amazonas, Brazil</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Universidade Nilton Lins, Manaus, Amazonas, Brazil</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Franco-Paredes</surname><given-names>Carlos</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Emory University, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">mmoraes@fiocruz.br</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn id="fn1" fn-type="current-aff"><label>¤</label><p>Current address: Divisions of Bacteriology and Parasitology, Tulane National Primate Research Center, Covington, Louisiana, United States of America.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>4</month><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>10</day><month>4</month><year>2014</year></pub-date>
<volume>8</volume>
<issue>4</issue>
<elocation-id>e2655</elocation-id>
<history>
<date date-type="received"><day>12</day><month>8</month><year>2013</year></date>
<date date-type="accepted"><day>7</day><month>11</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Martinez et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>In leprosy, classic diagnostic tools based on bacillary counts and histopathology have been facing hurdles, especially in distinguishing latent infection from active disease and diagnosing paucibacillary clinical forms. Serological tests and IFN-gamma releasing assays (IGRA) that employ humoral and cellular immune parameters, respectively, are also being used, but recent results indicate that quantitative PCR (qPCR) is a key technique due to its higher sensitivity and specificity. In fact, advances concerning the structure and function of the <italic>Mycobacterium leprae</italic> genome led to the development of specific PCR-based gene amplification assays for leprosy diagnosis and monitoring of household contacts. Also, based on the validation of point-of-care technologies for <italic>M. tuberculosis</italic> DNA detection, it is clear that the same advantages of rapid DNA detection could be observed in respect to leprosy. So far, PCR has proven useful in the determination of transmission routes, <italic>M. leprae</italic> viability, and drug resistance in leprosy. However, PCR has been ascertained to be especially valuable in diagnosing difficult cases like pure neural leprosy (PNL), paucibacillary (PB), and patients with atypical clinical presentation and histopathological features compatible with leprosy. Also, the detection of <italic>M. leprae</italic> DNA in different samples of the household contacts of leprosy patients is very promising. Although a positive PCR result is not sufficient to establish a causal relationship with disease outcome, quantitation provided by qPCR is clearly capable of indicating increased risk of developing the disease and could alert clinicians to follow these contacts more closely or even define rules for chemoprophylaxis.</p>
</abstract>
<funding-group><funding-statement>This study was funded by FAPEAM (Fundação de PEsquisa do Estado do Amazonas): Programa Estratégico de Ciência, Tecnologia &amp; Inovação nas Fundações Estaduais de Saúde - PECTI/AM - Saúde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="8"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Leprosy is a chronic infectious disease caused by <italic>M. leprae</italic>, a slow-growing intracellular mycobacteria with tropism for Schwann cell in nerves and macrophages in the skin. In some patients, the disease is challenging to diagnose since there is no gold-standard method to differentiate between infection and disease. Leprosy is also a neglected disease, being endemic in developing countries, where detection rates show only a slight trend toward a decrease in disease (or number of cases) in spite of good treatment and the efforts of the World Health Organization (WHO) to improve the quality of leprosy control programs <xref ref-type="bibr" rid="pntd.0002655-Talhari1">[1]</xref>. It is accepted that transmission occurs from human to human through the upper airways, although intermediate hosts like armadillos may play a role in certain places, such as the United States <xref ref-type="bibr" rid="pntd.0002655-Truman1">[2]</xref>. It is generally held that untreated multibacillary (MB) patients are the most important source of transmission, which occurs when bacilli are spread—usually by airborne droplets from nasal and/or mouth. Hence, leprosy patients, especially those with high bacterial load, release billions of bacilli that can potentially contaminate their close relatives or household contacts. As a result, the contacts of leprosy patients are known to have a higher risk of illness than the general population. Surveillance of these contacts would be an easy control strategy to block transmission, as suggested by the World Health Organization.</p>
<p>However, the steady number of new cases of leprosy in endemic countries is thought to result from the perpetuating reservoir of <italic>M. leprae</italic>-infected contacts and/or from the difficulties of early clinical diagnosis. It has been shown that good surveillance of patients' contacts has increased the detection rate of less severe clinical presentations with lower bacteriological indices <xref ref-type="bibr" rid="pntd.0002655-HackerMde1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Ezenduka1">[4]</xref>.</p>
<p>Immunological tools to detect <italic>M. leprae</italic> are based on their ability to detect major unique components like phenolic glycolipid-I (PGL-I), specific proteins by means of monoclonal and polyclonal antibodies <xref ref-type="bibr" rid="pntd.0002655-Duthie1">[5]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Spencer1">[6]</xref>, or T cell immune response as measured by IFNγ production <xref ref-type="bibr" rid="pntd.0002655-Spencer2">[7]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Geluk1">[8]</xref>. Notwithstanding, the development of good diagnostic tests for leprosy is halted by the diversity of the strength of the cellular and humoral responses, varying from high to low (non)responders. On one hand, a major difficulty concerns paucibacillary (PB) forms, in which bacilli or antibodies against it are not easily detected in most cases. These PB patients exhibit cell-mediated immunity, secreting high levels of IFNγ after in vitro stimulation with specific <italic>M. leprae</italic> antigens (or a peptide fraction). On the other hand, MB patients do not produce IFNγ in vitro but have high bacillary loads that are easily identified by PCR or anti-PGL-I detection. Concerning IFNγ release, one problem in early diagnosis is that most of the household contacts show a similar pattern of IFNγ secretion as that of PB patients <xref ref-type="bibr" rid="pntd.0002655-Martins1">[9]</xref>. Generally, contacts exhibit a sustained high production of IFNγ that is dependent on continuous exposure to an infective source, i.e., a MB or sometimes a PB patient.</p>
<p>Both serological and immunological tests have limitations, and neither one can be considered a reliable diagnostic tool. Nevertheless, it is known that experienced clinicians and well-equipped clinics with histopathological examinations and bacillary counts, along with other clinical tests, available can diagnose most of the cases. However, the lack of a gold standard test for leprosy and the inability to distinguish infected individuals from those exhibiting active disease makes leprosy diagnosis essentially based on clinical features. Given that recognition of the disease is required, late diagnosis is relatively frequent in many patients. In addition, the lack of a specific and sensitive test to determine whether the infection has progressed to active disease makes it difficult to interrupt the transmission chain and impairs leprosy control.</p>
<p>Detection by PCR of <italic>M. leprae</italic> DNA in difficult-to-diagnose cases favors correct diagnosis and the possibility of early identification. In fact, the development and constant improvement of molecular tests for leprosy diagnosis has revealed that clinical manifestations like pure neural leprosy (PNL) are much more common than originally thought <xref ref-type="bibr" rid="pntd.0002655-Antunes1">[10]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Jardim2">[12]</xref>. Here, we review several studies that discuss PCR usefulness in the clinical practice, such as in indeterminate leprosy, with patients who have clinical signs of leprosy but no confirmation through routine tests and histopathology, in difficult-to-diagnose cases, and in early detection in household contacts (<xref ref-type="boxed-text" rid="pntd-0002655-box001">Box 1</xref>).</p>
<boxed-text id="pntd-0002655-box001" position="float"><sec id="s1a1">
<title>Box 1. There Is a Future for PCR in Leprosy Diagnosis</title>
<list list-type="bullet"><list-item>
<p>Surveillance of household contacts of leprosy patients favors early diagnosis of the disease.</p>
</list-item><list-item>
<p>Semiautomatic, large-scale, cost-affordable quantitative PCR (qPCR) could be used to screen high-risk contacts and indicate chemoprophylaxis;</p>
</list-item><list-item>
<p>qPCR can be used to diagnose leprosy in difficult-to-diagnose cases such as pure neural or atypical skin clinical presentations;</p>
</list-item><list-item>
<p>point-of-care molecular-based technologies are available and could be used for diagnosis of leprosy, among other neglected diseases.</p>
</list-item></list>
</sec></boxed-text></sec><sec id="s2">
<title>Historical Aspects of Biochemical and Genetic Studies of <italic>M. leprae</italic></title>
<p>Historically, along with the spectrum of clinical forms of leprosy, one of the problems in developing new diagnostic tests has been an inability to grow <italic>M. leprae</italic> in vitro. Initial studies of biochemical and molecular features of this mycobacteria species could be achieved only after the development of techniques for growing leprosy bacillus in the mouse footpad <xref ref-type="bibr" rid="pntd.0002655-Shepard1">[13]</xref> and armadillos <xref ref-type="bibr" rid="pntd.0002655-Kirchheimer1">[14]</xref>. These models aided leprosy research, the development of new chemotherapeutic agents, and the confirmation of drug resistance and the antigenic and molecular structure of <italic>M. leprae</italic>.</p>
<p>The first methods to amplify <italic>M. leprae</italic> DNA, based on polymerase chain reaction (PCR), were developed a little longer than 20 years ago <xref ref-type="bibr" rid="pntd.0002655-Woods1">[15]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Hartskeerl1">[16]</xref>. Later, another wave of significant progress in understanding the molecular biology of <italic>M. leprae</italic> came about after the completion of the genome sequencing of the leprosy bacillus described by Cole and colleagues <xref ref-type="bibr" rid="pntd.0002655-Cole1">[17]</xref> came out, along with other mycobacterial genomes allowing comparisons <xref ref-type="bibr" rid="pntd.0002655-Cole2">[18]</xref>. Since then, bioinformatics and new-generation sequencing approaches have provided information capable of supporting studies aimed at a better understanding of <italic>M. leprae</italic> genetic diversity <xref ref-type="bibr" rid="pntd.0002655-Monot1">[19]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Monot2">[20]</xref>. In fact, it is astonishing that <italic>M. leprae</italic> has presented a very stable genome for a very long time. Samples recovered from skeletons are genetically conserved as compared to modern strains <xref ref-type="bibr" rid="pntd.0002655-Schuenemann1">[21]</xref>. The information about <italic>M. leprae</italic> genomes also enabled isolation and characterization of genes and expression profiles. Recently, DNA microarrays shed light on <italic>M. leprae</italic> gene function and provided further understanding of the pathogenesis of leprosy <xref ref-type="bibr" rid="pntd.0002655-Akama1">[22]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Williams2">[27]</xref>. In addition, these new technologies have proven useful in leprosy diagnosis, drug resistance detection, and for information about transmission and mycobacterial variability in high- and low-endemic areas <xref ref-type="bibr" rid="pntd.0002655-Fontes1">[28]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Xing1">[33]</xref>. Furthermore, a detailed review encloses information on pseudogenes, molecular epidemiology, and biology of <italic>M. leprae</italic> <xref ref-type="bibr" rid="pntd.0002655-Singh1">[34]</xref>; thus, these issues will not be covered here.</p>
</sec><sec id="s3">
<title>PCR as a Detection Tool</title>
<p>In the past 20 years, definitive identification of <italic>M. leprae</italic> has been possible through the development of methods for the extraction, amplification, and identification of <italic>M. leprae</italic> DNA in clinical specimens using PCR. This technique has been applied not only to skin biopsy samples, but also to several different types of specimens such as skin smears, nerves, urine, oral or nasal swabs, blood, and ocular lesions <xref ref-type="bibr" rid="pntd.0002655-Jardim1">[11]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Santos1">[35]</xref>–<xref ref-type="bibr" rid="pntd.0002655-daRosa1">[41]</xref>. Different sequences were used as targets for PCR, such as genes encoding the 36-kDa antigen <xref ref-type="bibr" rid="pntd.0002655-Kampirapap1">[42]</xref>, 18-kDa antigen <xref ref-type="bibr" rid="pntd.0002655-Scollard1">[43]</xref>, 65-kDa antigen <xref ref-type="bibr" rid="pntd.0002655-Plikaytis1">[44]</xref>, complex 85 <xref ref-type="bibr" rid="pntd.0002655-Martinez1">[37]</xref>, 16S rDNA <xref ref-type="bibr" rid="pntd.0002655-Martinez2">[45]</xref>, and the repetitive sequences <xref ref-type="bibr" rid="pntd.0002655-Adams1">[46]</xref> among other <italic>M. leprae</italic> genes. More recently, real-time PCR technology has improved detection, increasing sensitivity and specificity as it appears to be a robust tool for mycobacteria recognition in selected clinical situations, as well as for quantitation in experimental settings <xref ref-type="bibr" rid="pntd.0002655-Martinez1">[37]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Martinez2">[45]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Kramme1">[47]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Truman2">[50]</xref>.</p>
<p>One of the first studies based on PCR was carried out in 1990 by Williams and colleagues They established a procedure for detecting <italic>M. leprae</italic> DNA in infected tissues <xref ref-type="bibr" rid="pntd.0002655-Williams3">[51]</xref>. The PCR test was specific and detected <italic>M. leprae</italic> DNA in biopsies from leprosy patients. The evolution of PCR, as evaluated by technical issues (time and handling) but also by molecular and clinical sensitivity, is remarkable. In the early 1990s, radioactive probes were required to increase PCR sensitivity, and, hence, to overcome problems inherent to radioactivity, nonradioactive probes were developed <xref ref-type="bibr" rid="pntd.0002655-Scollard1">[43]</xref>. Also, nested PCR was introduced and employed to increase specificity and sensitivity, to avoid the use of radioactive probes, and to shorten the time required to obtain a result <xref ref-type="bibr" rid="pntd.0002655-Plikaytis1">[44]</xref>. Both studies demonstrated the emerging potential of PCR technology in the rapid detection and definitive identification of small numbers of <italic>M. leprae</italic> in clinical specimens.</p>
<p>The quality and the quantity of the isolated nucleic acid as well as the PCR target product size had tremendous effects on the success of amplification methods. Therefore, several protocols have been described for purification and amplification of <italic>M. leprae</italic> DNA, RNA, or both. Extractions that do not involve any purification step, for example, can inhibit the polymerase reaction due to impurities in the extract, as described by de Wit in 1991 <xref ref-type="bibr" rid="pntd.0002655-deWit2">[52]</xref>. Nevertheless, methods employing commercial kits have been consistently used and seem to be effective <xref ref-type="bibr" rid="pntd.0002655-Wen1">[53]</xref>, <xref ref-type="bibr" rid="pntd.0002655-daSilvaRocha1">[54]</xref>, although conditions to evaluate repeatability and other parameters to further explore the potential of the technique are still lacking. In parallel, extraction methods proved to be suitable for formalin-fixed samples and further amplification under certain conditions <xref ref-type="bibr" rid="pntd.0002655-MorgadodeAbreu1">[55]</xref>. Samples can also be easily stored in 70% ethanol and FTA cards for <italic>M. leprae</italic> DNA detection <xref ref-type="bibr" rid="pntd.0002655-Aye1">[56]</xref> exhibiting similar recovery rates.</p>
<p>Furthermore, the size of the PCR fragment amplified has to be taken into account as adaptation of conventional <xref ref-type="bibr" rid="pntd.0002655-deWit2">[52]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Goulart1">[57]</xref> to real-time PCR assays <xref ref-type="bibr" rid="pntd.0002655-Kramme1">[47]</xref> requires shorter length amplicons. An overall assessment of the impact of the PCR technology in leprosy diagnosis can be observed in <xref ref-type="table" rid="pntd-0002655-t001">Table 1</xref> using skin biopsy samples as an example. Also, irrespective of whether the detection method used is conventional or real-time PCR, smaller PCR products allow for better amplification efficiency from DNA extracted from either formalin- or ethanol-fixed or fresh tissues. In fact, an important advance has been the real-time PCR technology. This method allows direct quantitation of bacterial DNA content in clinical samples and has improved turnaround time and cost effectiveness (<xref ref-type="table" rid="pntd-0002655-t001">Table 1</xref>), permitting more reliable results. The procedure follows the general principle of PCR, and its key feature is that the amplified DNA or cDNA (complementary DNA) is quantitated as it accumulates in the reaction in real time after each amplification cycle. These real-time methods have improved slightly but consistently the analytical and clinical sensitivity when PB patients' samples were assessed in skin samples <xref ref-type="bibr" rid="pntd.0002655-Martinez1">[37]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Rudeeaneksin1">[48]</xref>. In addition, analyses using real-time PCR showed that total DNA content estimated by molecular levels could be correlated to bacterial load, corroborating the clinical data, which can be useful to determine a molecular bacteriological index, helping to define the clinical form of patients <xref ref-type="bibr" rid="pntd.0002655-Martinez1">[37]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Rudeeaneksin1">[48]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Truman2">[50]</xref>. Nevertheless, while PCR diagnosis is not needed for lepromatous patients with high bacillary load and high number of lesions, it is extremely helpful for the diagnosis of the already-mentioned situations such as clinical presentations with scarce number of <italic>M. leprae</italic> bacilli and difficult-to-diagnose patients.</p>
<table-wrap id="pntd-0002655-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0002655.t001</object-id><label>Table 1</label><caption>
<title>Selected results obtained by PCR assays tested in frozen and fresh skin biopsies from leprosy patients.</title>
</caption><alternatives><graphic id="pntd-0002655-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pntd.0002655.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">DNA Targets</td>
<td align="left" rowspan="1" colspan="1">PCR Method</td>
<td align="left" rowspan="1" colspan="1">Results</td>
<td align="left" rowspan="1" colspan="1">References</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Proline-rich antigen (pra-36 KDa)</td>
<td align="left" rowspan="1" colspan="1">PCR-Southern hybridization</td>
<td align="left" rowspan="1" colspan="1">87–100% MB, 36–60% PB</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Kampirapap1">[42]</xref>, <xref ref-type="bibr" rid="pntd.0002655-deWit2">[52]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Wichitwechkarn1">[96]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">TaqMan real-time PCR</td>
<td align="left" rowspan="1" colspan="1">89% BI<sup>+</sup>, 33% BI<sup>−</sup>.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Kramme1">[47]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">18 kDa</td>
<td align="left" rowspan="1" colspan="1">PCR-Southern hybridization</td>
<td align="left" rowspan="1" colspan="1">99% MB, 74% PB.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Williams4">[97]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">The specificity was 100%, and sensitivity ranged from 50% to 83%. A group of patients with other skin disorders was also tested.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Scollard1">[43]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RLEP</td>
<td align="left" rowspan="1" colspan="1">PCR-Southern hybridization</td>
<td align="left" rowspan="1" colspan="1">100% BI<sup>+</sup> or BI<sup>−</sup>.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Santos1">[35]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">PCR</td>
<td align="left" rowspan="1" colspan="1">100% MB, 73%, PB.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Goulart1">[57]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Yoon1">[98]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RLEP and TTC repeat</td>
<td align="left" rowspan="1" colspan="1">Multiplex-PCR</td>
<td align="left" rowspan="1" colspan="1">100% MB, 83% PB.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Banerjee1">[99]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RLEP</td>
<td align="left" rowspan="1" colspan="1">TaqMan real-time PCR</td>
<td align="left" rowspan="1" colspan="1">The specificity was 73%, and sensitivity was 91%.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Martinez4">[63]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ag85B</td>
<td align="left" rowspan="1" colspan="1">TaqMan real- time PCR</td>
<td align="left" rowspan="1" colspan="1">100% MB, 80% PB.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Martinez1">[37]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">The specificity was 100%, and sensitivity was 56%.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Martinez4">[63]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">16S</td>
<td align="left" rowspan="1" colspan="1">Taqman real-time PCR</td>
<td align="left" rowspan="1" colspan="1">The specificity was 100%, and sensitivity was 51%.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Martinez4">[63]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">16S</td>
<td align="left" rowspan="1" colspan="1">SyBr green real-time PCR</td>
<td align="left" rowspan="1" colspan="1">100% MB, 50% PB.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Rudeeaneksin1">[48]</xref></td>
</tr>
</tbody>
</table>
</alternatives></table-wrap></sec><sec id="s4">
<title>PCR for Diagnosis of Difficult Cases</title>
<sec id="s4a">
<title>Pure neural cases</title>
<p>PCR can aid in defining leprosy diagnosis in suspected patients with clinically suggestive or atypical lesions presenting with negative baciloscopy and inconclusive histopathology. This is true for primary neuritic or PNL patients, who are easily missed and misdirected since they do not exhibit cutaneous lesions <xref ref-type="bibr" rid="pntd.0002655-Jardim1">[11]</xref>. Timely treatment is imperative in these cases because, once nerve fibrosis occurs, damage is permanent and irreversible. Ridley and Jopling (R&amp;J) postulated that PNL might occur across the spectrum from borderline lepromatous (BL) to tuberculoid (TT) forms <xref ref-type="bibr" rid="pntd.0002655-Ridley1">[58]</xref>, but, in our experience, the PNL cases are indeterminate or borderline tuberculoid (BT) <xref ref-type="bibr" rid="pntd.0002655-Menicucci1">[59]</xref>. In fact, these patients cannot be classified according to the R&amp;J system because of the absence of skin lesions and clear histopathological features in the nerve. Nevertheless, a general WHO classification (paucibacillary) is used as none of them present bacilli in the slit-skin smears. A careful investigation examining skin biopsies (areas of skin hypoesthesia) described the histopathological features in the cutaneous lesions of PNL cases <xref ref-type="bibr" rid="pntd.0002655-Menicucci1">[59]</xref>. The assessment of PNL skin biopsies showed histopathological features consistent with normal skin, although indeterminate or borderline tuberculoid histological alterations were also detected. However, analysis of patients' nerve biopsies often showed detectable bacilli using Wade staining. It is curious that, even in endemic countries, leprosy is assumed to be a dermatologic disorder. Therefore, it is quite challenging to diagnose PNL cases <xref ref-type="bibr" rid="pntd.0002655-Antunes1">[10]</xref>. Neurologists are not expecting leprosy as a probable cause of peripheral neuropathy and, thus, laboratory techniques (i.e., histological evaluation, PCR from biopsy, and/or PGL-I in the serum) may be used along with pertinent clinical and electroneuromyographical data <xref ref-type="bibr" rid="pntd.0002655-Jardim2">[12]</xref>. In clinical practice, PCR is very useful in detecting <italic>M. leprae</italic> DNA in nerve specimens that have been shown to be bacteriologically negative by other methods of detection. In fact, Jardim and coworkers <xref ref-type="bibr" rid="pntd.0002655-Jardim2">[12]</xref> demonstrated that <italic>M. leprae</italic> infection in PNL cases is diagnosed most often by PCR, followed by anti-PGL-I antibodies and direct observation of the bacteria (acid-fast bacilli [AFB]). Hence, PCR is helpful and is being used as a confirmatory and diagnostic routine tool in difficult-to-diagnose cases such as PNL <xref ref-type="bibr" rid="pntd.0002655-BezerraDaCunha1">[60]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Rodriguez1">[62]</xref>.</p>
</sec><sec id="s4b">
<title>Differential diagnosis to other conditions</title>
<p>In an endemic country, leprosy is suspected in patients with anaesthesic lesions, although not necessarily so. PCR could be of immense help for dermatological differential diagnosis in hypochromic or granulomatous lesions, such as pityriasis alba, leishmaniasis, cutaneous tuberculosis (TB), and sarcoidosis, among other skin diseases in which pathological examination is inconclusive. There are few papers evaluating the application of PCR to solve this matter. Our retrospective analysis testing different gene targets (Ag 85B <xref ref-type="bibr" rid="pntd.0002655-Martinez1">[37]</xref>, <italic>sodA</italic> and 16S rRNA <xref ref-type="bibr" rid="pntd.0002655-Martinez2">[45]</xref>, and repetitive sequence [RLEP] <xref ref-type="bibr" rid="pntd.0002655-Truman2">[50]</xref>) using a panel of samples from patients previously diagnosed by pathologists and dermatologists, provided interesting information <xref ref-type="bibr" rid="pntd.0002655-Martinez4">[63]</xref>. When we include a higher proportion of paucibacillary samples (single skin indeterminate and tuberculoid forms), rates of PCR positivity decrease, but we were able to ascertain 50% of sensitivity. Obviously, that is expected since leprosy diagnosis is challenging in exactly these situations. Also, a group of other dermatological diseases were included as a negative control group, and the results suggest <xref ref-type="bibr" rid="pntd.0002655-Martinez4">[63]</xref> that some positive samples for PCR were misdiagnosed. These samples were defined initially as other dermatological diseases, but patients developed leprosy 10 years later, suggesting that PCR for <italic>M. leprae</italic> DNA could be a very early detection test for leprosy <xref ref-type="bibr" rid="pntd.0002655-Martinez4">[63]</xref>.</p>
</sec><sec id="s4c">
<title>PCR for treatment monitoring</title>
<p>In 1991, de Wit and coworkers <xref ref-type="bibr" rid="pntd.0002655-deWit2">[52]</xref> validated a PCR assay based on the selective amplification of a 530-bp fragment of the gene encoding the proline-rich antigen of <italic>M. leprae</italic> using clinical samples. They were able to detect the presence of <italic>M. leprae</italic> DNA on frozen biopsy sections from all untreated AFB-positive patients and 56% of the treated AFB-negative patients. The authors believed that PCR positivity reflected the presence of viable bacilli at the time of biopsy since a strong host immune response could result in killing of <italic>M. leprae</italic> and breakdown or clearance of its DNA in negative PCR samples.</p>
<p>Subsequent studies confirmed that PCR technology could be useful both for diagnosis and for assessment of viable load, as a reduction in signals was found to correlate with loss of viability. A follow-up study using patient's biopsies confirmed that <italic>M. leprae</italic> is rapidly killed after one month of multidrug therapy (MDT) treatment since MB cases declined by 54.3% and PB cases by 61.8% of initial positivity rate <xref ref-type="bibr" rid="pntd.0002655-Kampirapap1">[42]</xref>. However, because of the persistence of weak signals, in some cases a long time after effective treatment <xref ref-type="bibr" rid="pntd.0002655-Katoch1">[64]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Singh2">[65]</xref>, the authors concluded that DNA-based PCR assays lack the sensitivity to estimate any real impact of treatment on bacterial viability. Similarly, in 2001, Santos and colleagues <xref ref-type="bibr" rid="pntd.0002655-Santos2">[66]</xref> tested a PCR assay on different samples of leprosy patients that had completed MDT treatment. This PCR assay targeted a RLEP described previously and was able to detect <italic>M. leprae</italic> from hair bulb, blood, nasal secretion, lymph, and skin biopsy samples. Results demonstrated that 54.5% of the individuals were PCR positive in at least one of the samples 8 years after completion of MDT. However, it was not possible to draw final conclusions on the clinical significance of PCR positivity since assays were based on DNA detection and did not reflect viable bacilli.</p>
<p>To overcome this problem, several studies were conducted using reverse transcriptase-PCR (RT-PCR)-based assays for <italic>M. leprae</italic> viability estimation. It has been noted that an RNA-based test is likely to reflect only nucleic acids from living organisms, as the turnover rate of RNA is high, particularly in prokaryotes. Hence, methods based on a quantitative estimation of RNA levels in the tissues have been useful for monitoring therapeutic responses <xref ref-type="bibr" rid="pntd.0002655-Phetsuksiri1">[67]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Jadhav1">[69]</xref>. A PCR assay for monitoring bacterial clearance in leprosy patients during chemotherapy based on <italic>M. leprae</italic> 16S rRNA gene expression was described <xref ref-type="bibr" rid="pntd.0002655-Phetsuksiri1">[67]</xref>. After 6 months of MDT, they found that 44% of MB patients and 4% of PB patients tested still showed viable bacilli.</p>
<p>However, this assay was based only on the 16S rRNA, a relatively stable RNA species under several conditions, and was unable to detect rapid killing of <italic>M. leprae</italic>. Also, given that 16S rRNA gene is a housekeeping gene, a major drawback of these previous works is the lack of a gene target to normalize the template as an indicator of bacterial numbers in the specimen. Thus, Martinez and coworkers <xref ref-type="bibr" rid="pntd.0002655-Martinez2">[45]</xref> propose a real-time PCR integrated approach based on RNA/DNA ratios for viability determination, i.e., decrease of <italic>M. leprae</italic>-specific RNA is evaluated as a function of total <italic>M. leprae</italic> DNA content. Previous results demonstrated that a significant decrease in viability could be seen in vitro in as little as 48 hours post-treatment with rifampin. Also, analysis of human biopsies confirmed the correlation of MDT treatment and decline of gene expression level <xref ref-type="bibr" rid="pntd.0002655-Martinez2">[45]</xref>. This new approach may be helpful in the follow-up of leprosy patients on treatment and determination of drug resistance <xref ref-type="bibr" rid="pntd.0002655-Davis1">[70]</xref>. Also, other researchers have been using the same approach to estimate the viability in <italic>M. ulcerans</italic> (Buruli ulcers) and also in pathogenic fungi <xref ref-type="bibr" rid="pntd.0002655-Beissner1">[71]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Xie1">[72]</xref>. Interestingly, this method has been applied to estimate <italic>M. leprae</italic> viability in in vitro assays <xref ref-type="bibr" rid="pntd.0002655-Liu1">[73]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Teles1">[74]</xref>.</p>
<p>A recent and similar approach to monitor the effectiveness of chemotherapy using hsp18 as the gene target was developed by Lini and coworkers <xref ref-type="bibr" rid="pntd.0002655-Lini1">[75]</xref>. The copy number of bacterial DNA and hsp18 mRNA was estimated from 47 leprosy patients during treatment using paraffin-embedded biopsy samples. A reduction in DNA and mRNA during chemotherapy was observed, and hsp18 mRNA could not be detected in patients who underwent 2 years of MDT. Ten years ago, WHO recommended shortening the treatment to 12 months, although no molecular studies compared both regimens. Anyways, since there are no clear epidemiological alterations in relapse rates as examples, it could be suggested that indeed all <italic>M. leprae</italic> is being killed after 12 months of treatment, although a considerable amount of <italic>M. leprae</italic> DNA remained in the skin after 2 years of MDT. Also, recent molecular epidemiological evidence indicates that reinfection is more common than relapse in second episodes of the disease emerging <xref ref-type="bibr" rid="pntd.0002655-daSilvaRocha2">[76]</xref>.</p>
</sec><sec id="s4d">
<title>PCR for the study of leprosy transmission and household contact surveillance</title>
<p>It is clear that household contact examination and follow-up is a determinant of leprosy control <xref ref-type="bibr" rid="pntd.0002655-HackerMde1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Ezenduka1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Sarno1">[77]</xref>. The arsenal of laboratory exams to screen this population could increase detection and early diagnosis. Several findings about leprosy indicate that <italic>M. leprae</italic> transmission mainly occurs by airborne droplet inhalation of <italic>M. leprae</italic>. Therefore, for purposes of clinical practice, the application of PCR for detection of <italic>M. leprae</italic> DNA in nasal swab samples from healthy individuals and household contacts has been reported <xref ref-type="bibr" rid="pntd.0002655-Almeida1">[36]</xref>, <xref ref-type="bibr" rid="pntd.0002655-deWit1">[39]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Lavania1">[78]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Beyene1">[79]</xref>. Results provided evidence that a majority of MB patients carry <italic>M. leprae</italic> in their nasal mucosa and that carriage of <italic>M. leprae</italic> occurs among healthy people living in an area where leprosy is endemic <xref ref-type="bibr" rid="pntd.0002655-Lavania1">[78]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Klatser1">[80]</xref>. In household contacts, detection of <italic>M. leprae</italic> DNA by PCR in nasal swabs does not infer whether the contact will progress to active disease. DNA detection rates in nasal swabs in contacts vary from 1 to 10% (<xref ref-type="table" rid="pntd-0002655-t002">Table 2</xref>), which sometimes depends on the clinical form of the index cases. The data are not conclusive because prospective studies enrolling high numbers of contacts are still lacking. However, the high positivity rates observed among healthy individuals (<xref ref-type="table" rid="pntd-0002655-t002">Table 2</xref>) question the feasibility of the use of PCR in this site to predict the risk of developing the disease. Nevertheless, it has been shown that positive PGL-I test among contacts can increase the risk of developing leprosy <xref ref-type="bibr" rid="pntd.0002655-Duppre1">[81]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Hacker1">[82]</xref>. More recently, a very interesting study indicates that, indeed, the risk of progressing to active disease increases if a contact tests positive for PCR in the blood <xref ref-type="bibr" rid="pntd.0002655-Reis1">[83]</xref>. Thus, it is likely that a PGL-I test in combination with PCR could help identify the population at highest risk among household contacts <xref ref-type="bibr" rid="pntd.0002655-Araujo1">[84]</xref>.</p>
<table-wrap id="pntd-0002655-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0002655.t002</object-id><label>Table 2</label><caption>
<title>Selected data showing PCR assays tested in nasal swabs or blood from healthy individuals and household contacts.</title>
</caption><alternatives><graphic id="pntd-0002655-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pntd.0002655.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">DNA Targets</td>
<td align="left" rowspan="1" colspan="1">PCR Method</td>
<td align="left" rowspan="1" colspan="1">Sample</td>
<td align="left" rowspan="1" colspan="1">Population</td>
<td align="left" rowspan="1" colspan="1">Results</td>
<td align="left" rowspan="1" colspan="1">References</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Proline-rich antigen (pra-36 KDa)</td>
<td align="left" rowspan="1" colspan="1">PCR-Southern hybridization</td>
<td align="left" rowspan="1" colspan="1">Nasal swab</td>
<td align="left" rowspan="1" colspan="1">Healthy</td>
<td align="left" rowspan="1" colspan="1">7.8%</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Klatser1">[80]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">PCR-ELISA</td>
<td align="left" rowspan="1" colspan="1">Nasal swab</td>
<td align="left" rowspan="1" colspan="1">Healthy</td>
<td align="left" rowspan="1" colspan="1">7.8%</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Beyene1">[79]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RLEP</td>
<td align="left" rowspan="1" colspan="1">PCR</td>
<td align="left" rowspan="1" colspan="1">Nasal swab</td>
<td align="left" rowspan="1" colspan="1">Healthy</td>
<td align="left" rowspan="1" colspan="1">31%</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Lavania1">[78]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Nasal swab</td>
<td align="left" rowspan="1" colspan="1">Household contacts</td>
<td align="left" rowspan="1" colspan="1">5.2% MB IC<xref ref-type="table-fn" rid="nt101">*</xref>, 3.8% PB IC.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Araujo1">[84]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Nasal swab</td>
<td align="left" rowspan="1" colspan="1">Household contacts</td>
<td align="left" rowspan="1" colspan="1">10% MB IC, 6% PB IC.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Cabral1">[100]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RLEP and TTC repeat</td>
<td align="left" rowspan="1" colspan="1">Multiplex-PCR</td>
<td align="left" rowspan="1" colspan="1">Nasal swabs</td>
<td align="left" rowspan="1" colspan="1">Household contacts</td>
<td align="left" rowspan="1" colspan="1">11% MB IC, 1.3% PB IC.</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Banerjee1">[99]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">ML0024</td>
<td align="left" rowspan="1" colspan="1">Real-time PCR</td>
<td align="left" rowspan="1" colspan="1">Blood</td>
<td align="left" rowspan="1" colspan="1">Household contacts</td>
<td align="left" rowspan="1" colspan="1">1.2%</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Reis1">[83]</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">RLEP</td>
<td align="left" rowspan="1" colspan="1">Nested PCR</td>
<td align="left" rowspan="1" colspan="1">Blood</td>
<td align="left" rowspan="1" colspan="1">Household contacts</td>
<td align="left" rowspan="1" colspan="1">6.25%</td>
<td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pntd.0002655-Wen1">[53]</xref></td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>*household contacts with multibacillary patients as index case (IC).</p></fn></table-wrap-foot></table-wrap>
<p>It is believed that humans are the only significant reservoir of infection in leprosy, but recent investigations reported the presence of <italic>M. leprae</italic> DNA in wild armadillos and environmental samples. Thus, studies in areas of high prevalence of the disease confirmed the presence of <italic>M. leprae</italic> in water samples in Indonesia <xref ref-type="bibr" rid="pntd.0002655-Lavania2">[85]</xref> and soil in India <xref ref-type="bibr" rid="pntd.0002655-Matsuoka1">[86]</xref> as potential sources of continued transmission of the disease. Also, Job and coworkers suggested that skin and nasal epithelia of untreated MB leprosy patients contribute to the shedding of <italic>M. leprae</italic> into the environment, which in turn increases the risk for household contacts <xref ref-type="bibr" rid="pntd.0002655-Job1">[87]</xref>. In addition, Truman and collaborators <xref ref-type="bibr" rid="pntd.0002655-Truman1">[2]</xref> used whole-genome sequencing to show that wild armadillos and American patients with leprosy in the southern United States are infected with the same strain of <italic>M. leprae</italic>. They were able to confirm that about a third of the leprosy autochthonous cases that arise each year in the United States almost certainly result from contact with infected armadillos.</p>
</sec></sec><sec id="s5">
<title>Technical Limitations and Future Perspectives of PCR-Mediated Leprosy Diagnosis</title>
<p>Although PCR could be a useful tool for the detection of subclinical infection, only a few investigations have consistently associated the presence of the <italic>M. leprae</italic> DNA with further development of the disease among household contacts <xref ref-type="bibr" rid="pntd.0002655-Reis1">[83]</xref>. However, PCR results associated with a serological test could improve the predictive value of PCR technology in leprosy diagnosis. In addition, the PCR-integrated approach based on RNA/DNA ratios for viability determination can be useful for assessment of infection rate with <italic>M. leprae</italic> within a population in the future. Earlier diagnosis of leprosy will be of great value in preventing more severe disease that may lead to disabilities. Chemotherapy at an early stage could preclude leprosy transmission and the consequences of late diagnosis.</p>
<p>In clinical practice, the detection of <italic>M. leprae</italic> by PCR in patients with negative baciloscopy or inconclusive histopathology would be of great value to define leprosy diagnosis. Thus, choosing the right target for an improvement in sensitivity is important. The use of a repetitive sequence as a PCR target DNA, for example, provides the advantage of higher sensitivity over other targets in the DNA because it is present at multiple sites in genomic DNA <xref ref-type="bibr" rid="pntd.0002655-Kang1">[88]</xref>. However, specificity of a repetitive sequence as a PCR target is an issue since we observed that it is lower than other assays. For this reason, although it seems encouraging, highest sensitivity has to be interpreted with great care. The RLEP gene target is highly conserved and, as a result, many homologous sequences may be present in other <italic>Mycobacterium</italic> species that have not been thoroughly investigated, generating false positive results, as reported for the <italic>M. tuberculosis</italic> IS6110 marker elsewhere <xref ref-type="bibr" rid="pntd.0002655-Kent1">[89]</xref>. So far, gene targets such as 16S and Ag85B could be considered a good cost-benefit ratio concerning specificity and sensitivity (<xref ref-type="table" rid="pntd-0002655-t001">Table 1</xref>) <xref ref-type="bibr" rid="pntd.0002655-Martinez4">[63]</xref>. This also argues against results detecting “<italic>M. leprae</italic>” DNA in water or soil <xref ref-type="bibr" rid="pntd.0002655-Lavania2">[85]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Matsuoka1">[86]</xref>.</p>
<p>For routine application of PCR, some operational aspects such as the invasive nature of the sample collection should be considered. Therefore, comparative studies of different types of clinical samples for leprosy diagnosis have been carried out. Less invasive samples such as blood, urine, nasal swab, hair bulbs, and, most importantly, slit-skin smears were accessed, and, although results were encouraging, they were less efficient than those obtained with skin biopsies; skin biopsies would be the best sample for household contacts screen if not for the ethical considerations <xref ref-type="bibr" rid="pntd.0002655-Santos1">[35]</xref>, <xref ref-type="bibr" rid="pntd.0002655-Santos3">[90]</xref>. Nevertheless, amplification of <italic>M. leprae</italic> in blood samples, for example, gives inferior results in comparison to those using other types of clinical material <xref ref-type="bibr" rid="pntd.0002655-Santos1">[35]</xref>. Even though biopsy sampling of the lesion is obtained through an invasive method, it is the choice in most studies as it provides the highest PCR positivity rates.</p>
<p>So far, a well-characterized, commercial test for detection of <italic>M. leprae</italic> DNA in patients' samples is not available. Therefore, many labs continue to report results using their own definitions of sensitivity and specificity, and, in most cases, the results are not comparable across different clinical applications. Currently, several specific <italic>M. leprae</italic> genes of interest have been identified, and, thus, assays based on existing simple automated machines such as the GeneXpert assay for diagnosis of <italic>M. tuberculosis</italic> infection <xref ref-type="bibr" rid="pntd.0002655-Boehme1">[91]</xref> could be developed for leprosy. The Xpert MTB/RIF detects DNA sequences specific for <italic>M. tuberculosis</italic> and rifampicin resistance by PCR and is a major advance for TB diagnostics, especially for multidrug-resistant (MDR) TB and HIV-associated TB. Additional new technologies for miniature “lab on a chip” <xref ref-type="bibr" rid="pntd.0002655-Dockrell1">[92]</xref> and lateral flow assays <xref ref-type="bibr" rid="pntd.0002655-Hungria1">[93]</xref>–<xref ref-type="bibr" rid="pntd.0002655-Lobato1">[95]</xref> are also progressing so quickly that such assays would be feasible at point–of-care to improve clinical management decisions on leprosy diagnosis.</p>
<p>No data exist concerning the relative performance of different laboratories and methods for <italic>M. leprae</italic> DNA detection. An external quality assurance study on diagnostic proficiency that includes certifying and publishing the results in a comparative and anonymous manner would be highly recommended for leprosy diagnosis. Validation of paramount issues like adequate clinical material, nucleic acid extraction methods, sensitivity, specificity, PCR inhibition, and control of contamination will assure a reliable diagnosis of the disease. Thus, comparative testing of characterized samples would be a direct way to identify weaknesses of individual laboratories or certain methods. Furthermore, the positive predictive value (PPV) is another means of evaluating the usefulness of a diagnostic test as it reveals the probability that a positive result reflects the underlying condition being tested for. Its value does, however, depend on the prevalence of the disease, which may vary. Similarly, the negative predictive value (NPV) determines the proportion of patients with negative results who are correctly diagnosed. Although very useful, these values are difficult to apply to leprosy diagnosis due to the lack of a true gold standard method.</p>
</sec><sec id="s6">
<title>Conclusions</title>
<p>Overall, extensive evaluation of PCR tests in field studies has shown that DNA-based PCR assays can be 100% specific, while the sensitivity ranges from 34 to 80% in patients with PB forms to greater than 90% in patients with MB forms of the disease (<xref ref-type="table" rid="pntd-0002655-t001">Table 1</xref>). Also, since finding <italic>M. leprae</italic> is crucial in the confirmatory diagnosis of early leprosy, the use of PCR technique to enhance the ascertainment of difficult cases such as early PB and PNL is advisable and important in reaching a definitive diagnosis (<xref ref-type="boxed-text" rid="pntd-0002655-box002">Box 2</xref>). Thus, performing PCR to detect <italic>M. leprae</italic> DNA in difficult-to-diagnose cases can be executed in thousands of samples, favoring early identification and early treatment and helping to interrupt the transmission chain. Moreover, definitions of <italic>M. leprae</italic> strains could be very helpful in leprosy transmission. Undoubtedly, there is a future for PCR-based methods in relation to leprosy since these methods provide options for confirmation of diagnosis, treatment follow-up, detection of resistance, and, especially, support for the diagnosis of difficult cases such as PNL and PB.</p>
<boxed-text id="pntd-0002655-box002" position="float"><sec id="s6a1">
<title>Box 2. Top Five Papers in the Field</title>
<list list-type="order"><list-item>
<p>Reis EM, Araujo S, Lobato J, Neves AF, Costa AV, et al. (2013) Mycobacterium leprae DNA in peripheral blood may indicate a bacilli migration route and high-risk for leprosy onset. Clin Microbiol Infect. E-pub ahead of print. doi: 10.1111/1469-0691.12349</p>
</list-item><list-item>
<p>Ezenduka C, Post E, John S, Suraj A, Namadi A, et al. (2012) Cost-effectiveness analysis of three leprosy case detection methods in Northern Nigeria. PLOS Negl Trop Dis 6: e1818.</p>
</list-item><list-item>
<p>Martinez AN, Ribeiro-Alves M, Sarno EN, Moraes MO (2011) Evaluation of qPCR-based assays for leprosy diagnosis directly in clinical specimens. PLOS Negl Trop Dis 5: e1354.</p>
</list-item><list-item>
<p>Truman RW, Andrews PK, Robbins NY, Adams LB, Krahenbuhl JL, et al. (2008) Enumeration of Mycobacterium leprae using real-time PCR. PLOS Negl Trop Dis 2: e328.</p>
</list-item><list-item>
<p>Jardim MR, Antunes SL, Santos AR, Nascimento OJ, Nery JA, et al. (2003) Criteria for diagnosis of pure neural leprosy. J Neurol 250: 806–809.</p>
</list-item></list>
</sec></boxed-text></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pntd.0002655-Talhari1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Talhari</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grossi</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>de Oliveira</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Gontijo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Talhari</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Hansen's disease: a vanishing disease?</article-title> <source>Mem Inst Oswaldo Cruz</source> <volume>107 Suppl 1</volume>: <fpage>13</fpage>–<lpage>16</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Truman1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Truman</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Busso</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rougemont</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Probable zoonotic leprosy in the southern United States</article-title>. <source>N Engl J Med</source> <volume>364</volume>: <fpage>1626</fpage>–<lpage>1633</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-HackerMde1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hacker Mde</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Duppre</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Sales</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Sarno</surname><given-names>EN</given-names></name> (<year>2012</year>) <article-title>Characteristics of leprosy diagnosed through the surveillance of contacts: a comparison with index cases in Rio de Janeiro, 1987–2010</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>107 Suppl 1</volume>: <fpage>49</fpage>–<lpage>54</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Ezenduka1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ezenduka</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Post</surname><given-names>E</given-names></name>, <name name-style="western"><surname>John</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Suraj</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Namadi</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Cost-effectiveness analysis of three leprosy case detection methods in Northern Nigeria</article-title>. <source>PLOS Negl Trop Dis</source> <volume>6</volume>: <fpage>e1818</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Duthie1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duthie</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Truman</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>W</given-names></name>, <name name-style="western"><surname>O'Donnell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hay</surname><given-names>MN</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos</article-title>. <source>Clin Vaccine Immunol</source> <volume>18</volume>: <fpage>254</fpage>–<lpage>259</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Spencer1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spencer</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Wheat</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Chatterjee</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Balagon</surname><given-names>MV</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy</article-title>. <source>Clin Vaccine Immunol</source> <volume>18</volume>: <fpage>260</fpage>–<lpage>267</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Spencer2"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spencer</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Dockrell</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Marques</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Identification of specific proteins and peptides in mycobacterium leprae suitable for the selective diagnosis of leprosy</article-title>. <source>J Immunol</source> <volume>175</volume>: <fpage>7930</fpage>–<lpage>7938</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Geluk1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Geluk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Franken</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>van Meijgaarden</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Wieles</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection</article-title>. <source>Infect Immun</source> <volume>73</volume>: <fpage>5636</fpage>–<lpage>5644</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Martins1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martins</surname><given-names>MV</given-names></name>, <name name-style="western"><surname>Guimaraes</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Hacker</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>LS</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy</article-title>. <source>PLOS Negl Trop Dis</source> <volume>6</volume>: <fpage>e1616</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Antunes1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Antunes</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Chimelli</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jardim</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Vital</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Histopathological examination of nerve samples from pure neural leprosy patients: obtaining maximum information to improve diagnostic efficiency</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>107</volume>: <fpage>246</fpage>–<lpage>253</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Jardim1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jardim</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Antunes</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Nascimento</surname><given-names>OJ</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Criteria for diagnosis of pure neural leprosy</article-title>. <source>J Neurol</source> <volume>250</volume>: <fpage>806</fpage>–<lpage>809</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Jardim2"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jardim</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Antunes</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Simons</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wildenbeest</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Role of PGL-I antibody detection in the diagnosis of pure neural leprosy</article-title>. <source>Lepr Rev</source> <volume>76</volume>: <fpage>232</fpage>–<lpage>240</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Shepard1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shepard</surname><given-names>CC</given-names></name> (<year>1960</year>) <article-title>The Experimental Disease That Follows the Injection of Human Leprosy Bacilli into Foot-Pads of Mice</article-title>. <source>J Exp Med</source> <volume>112</volume>: <fpage>445</fpage>–<lpage>454</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Kirchheimer1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kirchheimer</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Storrs</surname><given-names>EE</given-names></name> (<year>1971</year>) <article-title>Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo</article-title>. <source>Int J Lepr Other Mycobact Dis</source> <volume>39</volume>: <fpage>693</fpage>–<lpage>702</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Woods1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woods</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Cole</surname><given-names>ST</given-names></name> (<year>1989</year>) <article-title>A rapid method for the detection of potentially viable Mycobacterium leprae in human biopsies: a novel application of PCR</article-title>. <source>FEMS Microbiol Lett</source> <volume>53</volume>: <fpage>305</fpage>–<lpage>309</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Hartskeerl1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hartskeerl</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Klatser</surname><given-names>PR</given-names></name> (<year>1989</year>) <article-title>Polymerase chain reaction for the detection of Mycobacterium leprae</article-title>. <source>J Gen Microbiol</source> <volume>135</volume>: <fpage>2357</fpage>–<lpage>2364</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Cole1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cole</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Eiglmeier</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Parkhill</surname><given-names>J</given-names></name>, <name name-style="western"><surname>James</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Thomson</surname><given-names>NR</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Massive gene decay in the leprosy bacillus</article-title>. <source>Nature</source> <volume>409</volume>: <fpage>1007</fpage>–<lpage>1011</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Cole2"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cole</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Brosch</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Parkhill</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Garnier</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Churcher</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence</article-title>. <source>Nature</source> <volume>393</volume>: <fpage>537</fpage>–<lpage>544</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Monot1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Monot</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Honore</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Garnier</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Araoz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Coppee</surname><given-names>JY</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>On the origin of leprosy</article-title>. <source>Science</source> <volume>308</volume>: <fpage>1040</fpage>–<lpage>1042</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Monot2"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Monot</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Honoré</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Garnier</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zidane</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sherafi</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Comparative genomic and phylogeographic analysis of Mycobacterium leprae</article-title>. <source>Nat Genet</source> <volume>41</volume>: <fpage>1282</fpage>–<lpage>1289</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Schuenemann1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schuenemann</surname><given-names>VJ</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mendum</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Krause-Kyora</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Jager</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Genome-wide comparison of medieval and modern Mycobacterium leprae</article-title>. <source>Science</source> <volume>341</volume>: <fpage>179</fpage>–<lpage>183</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Akama1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tanigawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kawashima</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Whole-genome expression analysis of Mycobacterium leprae and its clinical application</article-title>. <source>Jpn J Infect Dis</source> <volume>63</volume>: <fpage>387</fpage>–<lpage>392</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Akama2"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tanigawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kawashima</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ishii</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Analysis of Mycobacterium leprae gene expression using DNA microarray</article-title>. <source>Microb Pathog</source> <volume>49</volume>: <fpage>181</fpage>–<lpage>185</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Nakamura1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Akama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bang</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Sekimura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tanigawa</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Detection of RNA expression from pseudogenes and non-coding genomic regions of Mycobacterium leprae</article-title>. <source>Microb Pathog</source> <volume>47</volume>: <fpage>183</fpage>–<lpage>187</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Akama3"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tanigawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kawashima</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Whole-genome tiling array analysis of Mycobacterium leprae RNA reveals high expression of pseudogenes and noncoding regions</article-title>. <source>J Bacteriol</source> <volume>191</volume>: <fpage>3321</fpage>–<lpage>3327</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Williams1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Slayden</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Amin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Pittman</surname><given-names>TL</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Implications of high level pseudogene transcription in Mycobacterium leprae</article-title>. <source>BMC Genomics</source> <volume>10</volume>: <fpage>397</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Williams2"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Torrero</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Truman</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Yoder</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Biological implications of Mycobacterium leprae gene expression during infection</article-title>. <source>J Mol Microbiol Biotechnol</source> <volume>8</volume>: <fpage>58</fpage>–<lpage>72</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Fontes1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fontes</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Sakamuri</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Baptista</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Ura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Moraes</surname><given-names>MO</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Genetic diversity of mycobacterium leprae isolates from Brazilian leprosy patients</article-title>. <source>Lepr Rev</source> <volume>80</volume>: <fpage>302</fpage>–<lpage>315</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-CardonaCastro1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cardona-Castro</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Beltran-Alzate</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Romero-Montoya</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Melendez</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Identification and comparison of Mycobacterium leprae genotypes in two geographical regions of Colombia</article-title>. <source>Lepr Rev</source> <volume>80</volume>: <fpage>316</fpage>–<lpage>321</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Gillis1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gillis</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Vissa</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Matsuoka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Richardus</surname><given-names>JH</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Characterisation of short tandem repeats for genotyping Mycobacterium leprae</article-title>. <source>Lepr Rev</source> <volume>80</volume>: <fpage>250</fpage>–<lpage>260</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Shinde1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shinde</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sakamuri</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Reddy</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>VNTR typing of Mycobacterium leprae in South Indian leprosy patients</article-title>. <source>Lepr Rev</source> <volume>80</volume>: <fpage>290</fpage>–<lpage>301</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Srisungnam1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Srisungnam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rudeeaneksin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lukebua</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wattanapokayakit</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pasadorn</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Molecular epidemiology of leprosy based on VNTR typing in Thailand</article-title>. <source>Lepr Rev</source> <volume>80</volume>: <fpage>280</fpage>–<lpage>289</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Xing1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sakamuri</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>VNTR typing studies of Mycobacterium leprae in China: assessment of methods and stability of markers during treatment</article-title>. <source>Lepr Rev</source> <volume>80</volume>: <fpage>261</fpage>–<lpage>271</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Singh1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Singh</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cole</surname><given-names>ST</given-names></name> (<year>2011</year>) <article-title>Mycobacterium leprae: genes, pseudogenes and genetic diversity</article-title>. <source>Future Microbiol</source> <volume>6</volume>: <fpage>57</fpage>–<lpage>71</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Santos1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Santos</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>De Miranda</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Sarno</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Suffys</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Degrave</surname><given-names>WM</given-names></name> (<year>1993</year>) <article-title>Use of PCR-mediated amplification of Mycobacterium leprae DNA in different types of clinical samples for the diagnosis of leprosy</article-title>. <source>J Med Microbiol</source> <volume>39</volume>: <fpage>298</fpage>–<lpage>304</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Almeida1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Almeida</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Maniero</surname><given-names>VC</given-names></name>, <name name-style="western"><surname>Sales</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Duppre</surname><given-names>NC</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood and nasal secretion of Brazilian household contacts</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>99</volume>: <fpage>509</fpage>–<lpage>511</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Martinez1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Britto</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Sampaio</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Jardim</surname><given-names>MR</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy</article-title>. <source>J Clin Microbiol</source> <volume>44</volume>: <fpage>3154</fpage>–<lpage>3159</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Shamsi1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shamsi</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Chaudhry</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Moraes</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Riley</surname><given-names>FC</given-names></name> (<year>2007</year>) <article-title>Detection of Mycobacterium leprae in ocular tissues by histopathology and real-time polymerase chain reaction</article-title>. <source>Ophthalmic Res</source> <volume>39</volume>: <fpage>63</fpage>–<lpage>68</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-deWit1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Wit</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>McFadden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Klatser</surname><given-names>PR</given-names></name> (<year>1993</year>) <article-title>Polymerase chain reaction for detection of Mycobacterium leprae in nasal swab specimens</article-title>. <source>J Clin Microbiol</source> <volume>31</volume>: <fpage>502</fpage>–<lpage>506</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Caleffi1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caleffi</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Caleffi</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Siqueira</surname><given-names>VL</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Use of the polymerase chain reaction to detect Mycobacterium leprae in urine</article-title>. <source>Braz J Med Biol Res</source> <volume>45</volume>: <fpage>153</fpage>–<lpage>157</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-daRosa1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>da Rosa</surname><given-names>FB</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>VC</given-names></name>, <name name-style="western"><surname>de Almeida</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>do Nascimento</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Vasquez</surname><given-names>FG</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Detection of Mycobacterium leprae in saliva and the evaluation of oral sensitivity in patients with leprosy</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>108</volume>: <fpage>572</fpage>–<lpage>577</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Kampirapap1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kampirapap</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Singtham</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Klatser</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Wiriyawipart</surname><given-names>S</given-names></name> (<year>1998</year>) <article-title>DNA amplification for detection of leprosy and assessment of efficacy of leprosy chemotherapy</article-title>. <source>Int J Lepr Other Mycobact Dis</source> <volume>66</volume>: <fpage>16</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Scollard1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scollard</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Gillis</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name> (<year>1998</year>) <article-title>Polymerase chain reaction assay for the detection and identification of Mycobacterium leprae in patients in the United States</article-title>. <source>Am J Clin Pathol</source> <volume>109</volume>: <fpage>642</fpage>–<lpage>646</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Plikaytis1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Plikaytis</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Gelber</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Shinnick</surname><given-names>TM</given-names></name> (<year>1990</year>) <article-title>Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay</article-title>. <source>J Clin Microbiol</source> <volume>28</volume>: <fpage>1913</fpage>–<lpage>1917</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Martinez2"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Lahiri</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pittman</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Scollard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Truman</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Molecular determination of Mycobacterium leprae viability by use of real-time PCR</article-title>. <source>J Clin Microbiol</source> <volume>47</volume>: <fpage>2124</fpage>–<lpage>2130</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Adams1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adams</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Pena</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hagge</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Schurr</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Insights from animal models on the immunogenetics of leprosy: a review</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>107 Suppl 1</volume>: <fpage>197</fpage>–<lpage>208</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Kramme1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kramme</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bretzel</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Panning</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kawuma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Drosten</surname><given-names>C</given-names></name> (<year>2004</year>) <article-title>Detection and quantification of Mycobacterium leprae in tissue samples by real-time PCR</article-title>. <source>Med Microbiol Immunol</source> <volume>193</volume>: <fpage>189</fpage>–<lpage>193</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Rudeeaneksin1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rudeeaneksin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Srisungngam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sawanpanyalert</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sittiwakin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Likanonsakul</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>LightCycler real-time PCR for rapid detection and quantitation of Mycobacterium leprae in skin specimens</article-title>. <source>FEMS Immunol Med Microbiol</source> <volume>54</volume>: <fpage>263</fpage>–<lpage>270</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Martinez3"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Ribeiro-Alves</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sarno</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Moraes</surname><given-names>MO</given-names></name> (<year>2011</year>) <article-title>Evaluation of qPCR-Based Assays for Leprosy Diagnosis Directly in Clinical Specimens</article-title>. <source>PLOS Negl Trop Dis</source> <volume>5</volume>: <fpage>e1354</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Truman2"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Truman</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>NY</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Krahenbuhl</surname><given-names>JL</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Enumeration of Mycobacterium leprae using real-time PCR</article-title>. <source>PLOS Negl Trop Dis</source> <volume>2</volume>: <fpage>e328</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Williams3"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Gillis</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Booth</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Looker</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>JD</given-names></name> (<year>1990</year>) <article-title>The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae</article-title>. <source>J Infect Dis</source> <volume>162</volume>: <fpage>193</fpage>–<lpage>200</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-deWit2"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Wit</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Faber</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Krieg</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Lucas</surname><given-names>SB</given-names></name>, <etal>et al</etal>. (<year>1991</year>) <article-title>Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues</article-title>. <source>J Clin Microbiol</source> <volume>29</volume>: <fpage>906</fpage>–<lpage>910</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Wen1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Whole-Blood Nested-PCR Amplification of M. leprae-Specific DNA for Early Diagnosis of Leprosy</article-title>. <source>Am J Trop Med Hyg</source> <volume>88</volume>: <fpage>918</fpage>–<lpage>922</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-daSilvaRocha1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>da Silva Rocha</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cunha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Diniz</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Salgado</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Aires</surname><given-names>MA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients</article-title>. <source>J Clin Microbiol</source> <volume>50</volume>: <fpage>1912</fpage>–<lpage>1917</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-MorgadodeAbreu1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morgado de Abreu</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Roselino</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Enokihara</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nonogaki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Prestes-Carneiro</surname><given-names>LE</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Mycobacterium leprae is identified in the oral mucosa from paucibacillary and multibacillary leprosy patients</article-title>. <source>Clin Microbiol Infect</source> <comment>E-pub ahead of print. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/1469-0691.12190" xlink:type="simple">10.1111/1469-0691.12190</ext-link></comment></mixed-citation>
</ref>
<ref id="pntd.0002655-Aye1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aye</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Matsuoka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kyaw</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Win</surname><given-names>AA</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>FTA card utility for PCR detection of Mycobacterium leprae</article-title>. <source>Jpn J Infect Dis</source> <volume>64</volume>: <fpage>246</fpage>–<lpage>248</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Goulart1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goulart</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Cardoso</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>JE</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size</article-title>. <source>Arch Dermatol Res</source> <volume>299</volume>: <fpage>267</fpage>–<lpage>271</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Ridley1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ridley</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Jopling</surname><given-names>WH</given-names></name> (<year>1966</year>) <article-title>Classification of leprosy according to immunity. A five-group system</article-title>. <source>Int J Lepr Other Mycobact Dis</source> <volume>34</volume>: <fpage>255</fpage>–<lpage>273</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Menicucci1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Menicucci</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Antunes</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Jardim</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>da Costa Nery</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Microscopic leprosy skin lesions in primary neuritic leprosy</article-title>. <source>J Am Acad Dermatol</source> <volume>52</volume>: <fpage>648</fpage>–<lpage>652</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-BezerraDaCunha1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bezerra Da Cunha</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Werneck</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Scola</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Werneck</surname><given-names>LC</given-names></name> (<year>2006</year>) <article-title>Pure neural leprosy: diagnostic value of the polymerase chain reaction</article-title>. <source>Muscle Nerve</source> <volume>33</volume>: <fpage>409</fpage>–<lpage>414</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Medeiros1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Medeiros</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Jardim</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Vital</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Costa Nery</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Sales</surname><given-names>AM</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>An Attempt to Improve Pure Neural Leprosy Diagnosis Using Immunohistochemistry Tests in Peripheral Nerve Biopsy Specimens</article-title>. <source>Appl Immunohistochem Mol Morphol</source> <comment>E-pub ahead of print. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PAI.0b013e31828dc70c." xlink:type="simple">10.1097/PAI.0b013e31828dc70c.</ext-link></comment></mixed-citation>
</ref>
<ref id="pntd.0002655-Rodriguez1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rodriguez</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pinto</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gomez</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Rengifo</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Estrada</surname><given-names>OL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Pure neuritic leprosy in patients from a high endemic region of Colombia</article-title>. <source>Lepr Rev</source> <volume>84</volume>: <fpage>41</fpage>–<lpage>50</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Martinez4"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Ribeiro-Alves</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sarno</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Moraes</surname><given-names>MO</given-names></name> (<year>2011</year>) <article-title>Evaluation of qPCR-based assays for leprosy diagnosis directly in clinical specimens</article-title>. <source>PLOS Negl Trop Dis</source> <volume>5</volume>: <fpage>e1354</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Katoch1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Katoch</surname><given-names>VM</given-names></name> (<year>2002</year>) <article-title>Advances in the diagnosis and treatment of leprosy</article-title>. <source>Expert Rev Mol Med</source> <volume>4</volume>: <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Singh2"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Singh</surname><given-names>HB</given-names></name>, <name name-style="western"><surname>Katoch</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Natrajan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>UD</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline</article-title>. <source>Acta Leprol</source> <volume>11</volume>: <fpage>179</fpage>–<lpage>182</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Santos2"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Santos</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Balassiano</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Pereira</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>PB</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>96</volume>: <fpage>1129</fpage>–<lpage>1133</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Phetsuksiri1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Phetsuksiri</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Rudeeaneksin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Supapkul</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wachapong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mahotarn</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>A simplified reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens</article-title>. <source>FEMS Immunol Med Microbiol</source> <volume>48</volume>: <fpage>319</fpage>–<lpage>328</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Kurabachew1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kurabachew</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wondimu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ryon</surname><given-names>JJ</given-names></name> (<year>1998</year>) <article-title>Reverse transcription-PCR detection of Mycobacterium leprae in clinical specimens</article-title>. <source>J Clin Microbiol</source> <volume>36</volume>: <fpage>1352</fpage>–<lpage>1356</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Jadhav1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jadhav</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Kamble</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Shinde</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Edward</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Edward</surname><given-names>VK</given-names></name> (<year>2005</year>) <article-title>Use of reverse transcription polymerase chain reaction for the detection of Mycobacterium leprae in the slit-skin smears of leprosy patients</article-title>. <source>Indian J Lepr</source> <volume>77</volume>: <fpage>116</fpage>–<lpage>127</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Davis1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davis</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Ray</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Lahiri</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gillis</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Krahenbuhl</surname><given-names>JL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Molecular Assays for Determining Mycobacterium leprae Viability in Tissues of Experimentally Infected Mice</article-title>. <source>PLOS Negl Trop Dis</source> <volume>7</volume>: <fpage>e2404</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Beissner1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beissner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Symank</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>RO</given-names></name>, <name name-style="western"><surname>Amoako</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Awua-Boateng</surname><given-names>NY</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Detection of viable Mycobacterium ulcerans in clinical samples by a novel combined 16S rRNA reverse transcriptase/IS2404 real-time qPCR assay</article-title>. <source>PLOS Negl Trop Dis</source> <volume>6</volume>: <fpage>e1756</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Xie1"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kashleva</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dongari-Bagtzoglou</surname><given-names>A</given-names></name> (<year>2011</year>) <article-title>A quantitative real-time RT-PCR assay for mature C. albicans biofilms</article-title>. <source>BMC Microbiol</source> <volume>11</volume>: <fpage>93</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Liu1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>PT</given-names></name>, <name name-style="western"><surname>Wheelwright</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Teles</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Komisopoulou</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Edfeldt</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy</article-title>. <source>Nat Med</source> <volume>18</volume>: <fpage>267</fpage>–<lpage>273</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Teles1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Teles</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Graeber</surname><given-names>TG</given-names></name>, <name name-style="western"><surname>Krutzik</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Montoya</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Schenk</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title>. <source>Science</source> <volume>339</volume>: <fpage>1448</fpage>–<lpage>1453</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Lini1"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lini</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shankernarayan</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Dharmalingam</surname><given-names>K</given-names></name> (<year>2009</year>) <article-title>Quantitative real-time PCR analysis of Mycobacterium leprae DNA and mRNA in human biopsy material from leprosy and reactional cases</article-title>. <source>J Med Microbiol</source> <volume>58</volume>: <fpage>753</fpage>–<lpage>759</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-daSilvaRocha2"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>da Silva Rocha</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cunha Dos Santos</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Pignataro</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>de Miranda</surname><given-names>AB</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Genotyping of Mycobacterium leprae from Brazilian leprosy patients suggests the occurrence of reinfection or of bacterial population shift during disease relapse</article-title>. <source>J Med Microbiol</source> <volume>60</volume>: <fpage>1441</fpage>–<lpage>1446</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Sarno1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sarno</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Duppre</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Sales</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Hacker</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Leprosy exposure, infection and disease: a 25-year surveillance study of leprosy patient contacts</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>107</volume>: <fpage>1054</fpage>–<lpage>1059</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Lavania1"><label>78</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lavania</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Turankar</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Karri</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chaitanya</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Sengupta</surname><given-names>U</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Cohort study of the seasonal effect on nasal carriage and the presence of Mycobacterium leprae in an endemic area in the general population</article-title>. <source>Clin Microbiol Infect</source> <volume>19</volume>: <fpage>970</fpage>–<lpage>974</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Beyene1"><label>79</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beyene</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Aseffa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Harboe</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kidane</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Macdonald</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia</article-title>. <source>Epidemiol Infect</source> <volume>131</volume>: <fpage>841</fpage>–<lpage>848</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Klatser1"><label>80</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klatser</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>van Beers</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Madjid</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>R</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>MY</given-names></name> (<year>1993</year>) <article-title>Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic</article-title>. <source>J Clin Microbiol</source> <volume>31</volume>: <fpage>2947</fpage>–<lpage>2951</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Duppre1"><label>81</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duppre</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Camacho</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Sales</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Illarramendi</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study</article-title>. <source>PLOS Negl Trop Dis</source> <volume>6</volume>: <fpage>e1711</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Hacker1"><label>82</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hacker</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Sales</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Illarramendi</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Duppre</surname><given-names>NC</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A profile of patients treated at a national leprosy outpatient referral clinic in Rio de Janeiro, Brazil, 1986–2007</article-title>. <source>Rev Panam Salud Publica</source> <volume>31</volume>: <fpage>485</fpage>–<lpage>491</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Reis1"><label>83</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reis</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Araujo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lobato</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Neves</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>AV</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Mycobacterium leprae DNA in peripheral blood may indicate a bacilli migration route and high-risk for leprosy onset</article-title>. <source>Clin Microbiol Infect</source> <comment>E-pub ahead of print. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/1469-0691.12349." xlink:type="simple">10.1111/1469-0691.12349.</ext-link></comment></mixed-citation>
</ref>
<ref id="pntd.0002655-Araujo1"><label>84</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Araujo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lobato</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reis Ede</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Souza</surname><given-names>DO</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>MA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Unveiling healthy carriers and subclinical infections among household contacts of leprosy patients who play potential roles in the disease chain of transmission</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>107 Suppl 1</volume>: <fpage>55</fpage>–<lpage>59</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Lavania2"><label>85</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lavania</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Katoch</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Katoch</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Chauhan</surname><given-names>DS</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Detection of viable Mycobacterium leprae in soil samples: insights into possible sources of transmission of leprosy</article-title>. <source>Infect Genet Evol</source> <volume>8</volume>: <fpage>627</fpage>–<lpage>631</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Matsuoka1"><label>86</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matsuoka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Izumi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Budiawan</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakata</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Saeki</surname><given-names>K</given-names></name> (<year>1999</year>) <article-title>Mycobacterium leprae DNA in daily using water as a possible source of leprosy infection</article-title>. <source>Indian J Lepr</source> <volume>71</volume>: <fpage>61</fpage>–<lpage>67</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Job1"><label>87</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Job</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Jayakumar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kearney</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gillis</surname><given-names>TP</given-names></name> (<year>2008</year>) <article-title>Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR</article-title>. <source>Am J Trop Med Hyg</source> <volume>78</volume>: <fpage>518</fpage>–<lpage>521</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Kang1"><label>88</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kang</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Chae</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JP</given-names></name> (<year>2003</year>) <article-title>Comparison of two different PCR amplification products (the 18-kDa protein gene vs. RLEP repetitive sequence) in the diagnosis of Mycobacterium leprae</article-title>. <source>Clin Exp Dermatol</source> <volume>28</volume>: <fpage>420</fpage>–<lpage>424</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Kent1"><label>89</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kent</surname><given-names>L</given-names></name>, <name name-style="western"><surname>McHugh</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Billington</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Dale</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>SH</given-names></name> (<year>1995</year>) <article-title>Demonstration of homology between IS6110 of Mycobacterium tuberculosis and DNAs of other Mycobacterium spp.?</article-title> <source>J Clin Microbiol</source> <volume>33</volume>: <fpage>2290</fpage>–<lpage>2293</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Santos3"><label>90</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Santos</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Goes Filho</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Nery</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Duppre</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Gallo</surname><given-names>ME</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Evaluation of PCR mediated DNA amplification in non-invasive biological specimens for subclinical detection of Mycobacterium leprae</article-title>. <source>FEMS Immunol Med Microbiol</source> <volume>11</volume>: <fpage>113</fpage>–<lpage>120</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Boehme1"><label>91</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boehme</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Nabeta</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hillemann</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Nicol</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Shenai</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Rapid molecular detection of tuberculosis and rifampin resistance</article-title>. <source>N Engl J Med</source> <volume>363</volume>: <fpage>1005</fpage>–<lpage>1015</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Dockrell1"><label>92</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dockrell</surname><given-names>HM</given-names></name> (<year>2011</year>) <article-title>Keep the faith–leprosy still needs new diagnostic tools and laboratory research</article-title>. <source>Lepr Rev</source> <volume>82</volume>: <fpage>340</fpage>–<lpage>343</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Hungria1"><label>93</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hungria</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>de Oliveira</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>de Souza</surname><given-names>VN</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil</article-title>. <source>Mem Inst Oswaldo Cruz</source> <volume>107 Suppl 1</volume>: <fpage>104</fpage>–<lpage>111</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Duthie2"><label>94</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duthie</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Hay</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Rada</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Convit</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers</article-title>. <source>Eur J Clin Microbiol Infect Dis</source> <volume>30</volume>: <fpage>1257</fpage>–<lpage>1265</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Lobato1"><label>95</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lobato</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Reis Ede</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Spencer</surname><given-names>JS</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Comparison of three immunological tests for leprosy diagnosis and detection of subclinical infection</article-title>. <source>Lepr Rev</source> <volume>82</volume>: <fpage>389</fpage>–<lpage>401</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Wichitwechkarn1"><label>96</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wichitwechkarn</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Karnjan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shuntawuttisettee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sornprasit</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kampirapap</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Detection of Mycobacterium leprae infection by PCR</article-title>. <source>J Clin Microbiol</source> <volume>33</volume>: <fpage>45</fpage>–<lpage>49</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Williams4"><label>97</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Gillis</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Fiallo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Job</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Gelber</surname><given-names>RH</given-names></name>, <etal>et al</etal>. (<year>1992</year>) <article-title>Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR</article-title>. <source>Mol Cell Probes</source> <volume>6</volume>: <fpage>401</fpage>–<lpage>410</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Yoon1"><label>98</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoon</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Abalos</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Cellona</surname><given-names>RV</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Evaluation of polymerase chain reaction amplification of Mycobacterium leprae-specific repetitive sequence in biopsy specimens from leprosy patients</article-title>. <source>J Clin Microbiol</source> <volume>31</volume>: <fpage>895</fpage>–<lpage>899</lpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Banerjee1"><label>99</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sarkar</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mahapatra</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Guha</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Multiplex PCR technique could be an alternative approach for early detection of leprosy among close contacts–a pilot study from India</article-title>. <source>BMC Infect Dis</source> <volume>10</volume>: <fpage>252</fpage>.</mixed-citation>
</ref>
<ref id="pntd.0002655-Cabral1"><label>100</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cabral</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Junior</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Macedo</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Alves</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Goncalves</surname><given-names>TB</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Anti-PGL1 salivary IgA/IgM, serum IgG/IgM, and nasal Mycobacterium leprae DNA in individuals with household contact with leprosy</article-title>. <source>Int J Infect Dis</source> <volume>17</volume>: <fpage>e1005</fpage>–<lpage>1010</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>